 - Compare the efficacy of adjuvant temozolomide TMZ alone or in combination with thalidomide andor isotretinoin andor celecoxib, in terms of 6-month progression-free survival, in patients who have undergone radiotherapy for supratentorial glioblastoma multiforme. 